Policy Brief: Status of implementation of deworming during pregnancy in Kerala

This policy brief evaluates the implementation status of deworming during pregnancy in Kerala, focusing on albendazole administration post the 1st trimester. Soil-transmitted helminth (STH) infections pose significant risks to pregnant women, leading to complications like anemia and low birth weight.

Policy Brief: Albendazole- The Step Child of Maternal Healthcare System

This policy brief raises a concern about the persistently low rates of deworming among pregnant women, as reported through the Health Management Information System (HMIS) data. Deworming using a single dose of Albendazole during the pregnancy is an important component of the package of services under the ante-natal-care (ANC). The adverse effects of worm infestation on morbidity, malnutrition and other peri-natal outcomes are well documented. Yet coverage rates for albendazole remain significantly low compared to distribution of IFA and Ca tablets, both multi-dose, and the Tetanus Toxoid (TT) injection. This ‘coverage deficit’ for deworming service amounts to filling a ‘leaking bucket’. The helminths have the last laugh, notwithstanding the high coverage under other ANC components. It is high time that this deficit is eliminated with all seriousness.